Skip to main content
Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
30.15
+2.28 (8.18%)
Nov 20, 2024, 4:00 PM EST - Market closed

Tandem Diabetes Care Revenue

Tandem Diabetes Care had revenue of $243.97M in the quarter ending September 30, 2024, with 31.43% growth. This brings the company's revenue in the last twelve months to $854.35M, up 10.75% year-over-year. In the year 2023, Tandem Diabetes Care had annual revenue of $747.72M, down -6.68%.

Revenue (ttm)
$854.35M
Revenue Growth
+10.75%
P/S Ratio
2.30
Revenue / Employee
$355,980
Employees
2,400
Market Cap
1.98B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023747.72M-53.50M-6.68%
Dec 31, 2022801.22M98.42M14.00%
Dec 31, 2021702.80M203.97M40.89%
Dec 31, 2020498.83M136.53M37.68%
Dec 31, 2019362.31M178.44M97.05%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Astrana Health 1.72B
National HealthCare 1.22B
Omnicell 1.06B
Azenta 656.32M
Supernus Pharmaceuticals 651.97M
NeoGenomics 644.12M
Beam Therapeutics 349.64M
Mirum Pharmaceuticals 307.03M
Revenue Rankings

TNDM News

More News